283 related articles for article (PubMed ID: 10218675)
1. Cutaneous Waldenstrom macroglobulinemia in transformation.
Appenzeller P; Leith CP; Foucar K; Scott AA; Bigler CF; Thompson CT
Am J Dermatopathol; 1999 Apr; 21(2):151-5. PubMed ID: 10218675
[TBL] [Abstract][Full Text] [Related]
2. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.
Minzenmayer AN; Miranda RN; Powell PR; Parekh PK
J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928
[TBL] [Abstract][Full Text] [Related]
3. [Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia].
del Olmo J; España A; Idoate MA; Panizo C
Actas Dermosifiliogr; 2008 Mar; 99(2):138-44. PubMed ID: 18346436
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous macroglobulinosis: a report of 2 cases.
Gressier L; Hotz C; Lelièvre JD; Carlotti A; Buffet M; Wolkenstein P; Bagot M; Melica G; Ortonne N
Arch Dermatol; 2010 Feb; 146(2):165-9. PubMed ID: 20157027
[TBL] [Abstract][Full Text] [Related]
5. Specific cutaneous manifestations of Waldenström's macroglobulinaemia. A report of two cases.
Mascaro JM; Montserrat E; Estrach T; Feliu E; Ferrando J; Castel T; Mallolas J; Rozman C
Br J Dermatol; 1982 Feb; 106(2):217-22. PubMed ID: 6800395
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous macroglobulinosis as the initial presentation of Waldenström macroglobulinemia in a patient with a history of diffuse large B-cell lymphoma.
Shakeri A; Kaffenberger BH; Gru AA
J Cutan Pathol; 2018 Dec; 45(12):962-964. PubMed ID: 30073689
[No Abstract] [Full Text] [Related]
7. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
[TBL] [Abstract][Full Text] [Related]
8. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
[TBL] [Abstract][Full Text] [Related]
9. Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual event.
Zhang K; Farrell D; Jeyakumar D; O'Brien S; Zhao X; Rezk SA
Hum Pathol; 2019 Aug; 90():106-110. PubMed ID: 30342054
[TBL] [Abstract][Full Text] [Related]
10. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.
Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749
[TBL] [Abstract][Full Text] [Related]
11. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
[TBL] [Abstract][Full Text] [Related]
12. Waldenström macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibody.
Cobb MW; Domloge-Hultsch N; Frame JN; Yancey KB
Arch Dermatol; 1992 Mar; 128(3):372-6. PubMed ID: 1550370
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
15. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
Kapoor P; Paludo J; Ansell SM
Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of lymphoplasmacytic lymphoma].
Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations as initial presentation of Waldenstrom's macroglobulinemia.
Abdallah-Lotf M; Bourgeois-Droin C; Perronne V; Fouchard N; Michel S; Launay-Russ E; Granier F
Eur J Dermatol; 2003; 13(1):90-2. PubMed ID: 12609792
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia.
Kyriakou C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):865-874. PubMed ID: 30190024
[TBL] [Abstract][Full Text] [Related]
19. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
Jalali S; Ansell SM
Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lymphoplasmacytoid lymphoma (immunocytoma) with Waldenström's macroglobulinemia mimicking rosacea.
Colvin JH; Lamerson CL; Cualing H; Mutasim DF
J Am Acad Dermatol; 2003 Dec; 49(6):1159-62. PubMed ID: 14639408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
